Loading…
Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Legislative Progress
Introduced
February 5, 2026
Latest Action
February 5, 2026
Primary Sponsor
Frank Pallone, Jr.Democratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2026 · third_quarter · Food Industry (safety, labeling, etc.)
Hemp-Derived Cannabidiol (CBD) regulations and legislation Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.7366, Dietary Supplement Regulatory Uniformity Act, Entirety H.R.7407, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, Entirety H.R.10336, Dietary Supplement Innovation Act, Entirety
Client expense: Not reported · Firm income: $10,000
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Food Industry (safety, labeling, etc.)
Hemp-Derived Cannabidiol (CBD) regulations and legislation Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.7366, Dietary Supplement Regulatory Uniformity Act, Entirety H.R.7407, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, Entirety
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE